Nykode Therapeutics ASA — Director's Dealing 2021

Dec 3, 2021

1	Details of the closely associated enterprise
a)	Name	Datum AS
2	Details of the person discharging managerial responsibilities
a)	Name	Jan Haudemann-Andersen
b)	Position	Board Member
3	Reason for notification
a)	Initial notification/ Amendment	Initial
4	Details of issuer
a)	Name	Vaccibody AS
b)	LEI	254900UKQHWYZJD22017
5	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
a)	Description of the financial instrument, type of instrument	Shares in Vaccibody AS (ISIN: NO0010714785)
b)	Nature of the transaction	Acquisition of shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 74.60	94,000
d)	Aggregated information	Price	NOK 74.60
	-Average price,	Volume	94,000
	aggregated volume and total amount	Total amount	NOK 7,012,400
e)	Date of the transaction	03.12.2021
f)	Place of the transaction	MERK – Euronext Growth Oslo

1	Details of the closely associated enterprise
a)	Name	RASMUSSENGRUPPEN AS
2	Details of the person discharging managerial responsibilities
a)	Name	Trygve Lauvdal
b)	Position	Board Member
3	Reason for notification
a)	Initial notification/ Amendment	Initial
4	Details of issuer
a)	Name	Vaccibody AS
b)	LEI	254900UKQHWYZJD22017
5	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
a)	Description of the financial instrument, type of instrument	Shares in Vaccibody AS (ISIN: NO0010714785)
b)	Nature of the transaction	Acquisition of shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 74.60	94,000
d)	Aggregated information	Price	NOK 74.60
	-Average price,	Volume	94,000
	aggregated volume and total amount	Total amount	NOK 7,012,400
e)	Date of the transaction	03.12.2021
f)	Place of the transaction	MERK – Euronext Growth Oslo

1	Details of the closely associated enterprise
a)	Name	Caaby AS
2	Details of the person discharging managerial responsibilities
a)	Name	Christian Åbyholm
b)	Position	Board Member
3	Reason for notification
a)	Initial notification/ Amendment	Initial
4	Details of issuer
a)	Name	Vaccibody AS
b)	LEI	254900UKQHWYZJD22017
5	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
a)	Description of the financial instrument, type of instrument	Shares in Vaccibody AS (ISIN: NO0010714785)
b)	Nature of the transaction	Acquisition of shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 74.60	9,400
d)	Aggregated information	Price	NOK 74.60
	-Average price,	Volume	9,400
	aggregated volume and total amount	Total amount	NOK 701,240
e)	Date of the transaction	03.12.2021
f)	Place of the transaction	MERK – Euronext Growth Oslo

1	Details of the closely associated enterprise
a)	Name	Victoria India Fund AS
2	Details of the person discharging managerial responsibilities
a)	Name	Christian Åbyholm
b)	Position	Board Member
3	Reason for notification
a)	Initial notification/ Amendment	Initial
4	Details of issuer
a)	Name	Vaccibody AS
b)	LEI	254900UKQHWYZJD22017
5	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
a)	Description of the financial instrument, type of instrument	Shares in Vaccibody AS (ISIN: NO0010714785)
b)	Nature of the transaction	Acquisition of shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 74.60	84,600
d)	Aggregated information	Price	NOK 74.60
	-Average price,	Volume	84,600
	aggregated volume and total amount	Total amount	NOK 6,311,160
e)	Date of the transaction	03.12.2021
f)	Place of the transaction	MERK – Euronext Growth Oslo

1	Details of the closely associated enterprise
a)	Name	Viginti AS
2	Details of the person discharging managerial responsibilities
a)	Name	Agnete B. Fredriksen
b)	Position	Chief Innovation & Strategy Officer
3	Reason for notification
a)	Initial notification/ Amendment	Initial
4	Details of issuer
a)	Name	Vaccibody AS
b)	LEI	254900UKQHWYZJD22017
5	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
a)	Description of the financial instrument, type of instrument	Shares in Vaccibody AS (ISIN: NO0010714785)
b)	Nature of the transaction	Sale of shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 74.60	282,000
d)	Aggregated information	Price	NOK 74.60
	-Average price,	Volume	282,000
	aggregated volume and total amount	Total amount	NOK 21,037,200
e)	Date of the transaction	03.12.2021
f)	Place of the transaction	MERK – Euronext Growth Oslo